CAS: 2055597-12-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ERK-IN-3 REF: 54-BUP03270CAS: 2055597-12-9 | 99% | 429.00 €~1,207.00 € | Wed 30 Apr 25 |
 | ERK-IN-3 REF: TM-T9141CAS: 2055597-12-9 | 99.55% - 99.76% | 62.00 €~462.00 € | Tue 06 May 25 |
 | ERK-IN-3 REF: 3D-FHD59712CAS: 2055597-12-9 | Min. 95% | To inquire | Tue 10 Jun 25 |
Ref: 54-BUP03270
| 25mg | 429.00 € | ||
| 50mg | 689.00 € | ||
| 100mg | 1,207.00 € |
Estimated delivery in United States, on Wednesday 30 Apr 2025
ERK-IN-3
CAS:2055597-12-9
ERK-IN-3 (ASN007 free base) is a potent and orally active inhibitor of ERK.
Formula:
C22H25ClFN7O2
Purity:
99.55% - 99.76%
Color and Shape:
Solid
Molecular weight:
473.93
- Inhibitors
- MAPK
- Ras
- ERK
- See more categories
- Cancer Research Antibodies
Ref: TM-T9141
| 1mg | 62.00 € | ||
| 5mg | 124.00 € | ||
| 10mg | 173.00 € | ||
| 25mg | 283.00 € | ||
| 50mg | 462.00 € | ||
| 1mL*10mM (DMSO) | 125.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
ERK-IN-3
CAS:2055597-12-9
Please enquire for more information about ERK-IN-3 including the price, delivery time and more detailed …
Formula:
C22H25ClFN7O2
Purity:
Min. 95%
Molecular weight:
473.9 g/mol
Ref: 3D-FHD59712
| 25mg | 780.00 € | ||
| 50mg | 1,178.00 € | ||
| 100mg | 1,637.00 € |
Estimated delivery in United States, on Tuesday 10 Jun 2025
